Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1984-05-03
1987-03-24
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, A61K 4300, A61K 4900
Patent
active
046524401
ABSTRACT:
.sup.99 m Tc-labeling of antibodies and antibody fragments, either unconjugated or conjugated to DTPA, is effected in the presence of molar excess of free or carrier-bound DTPA to substantially completely inhibit direct technetium binding to non-stable binding sites on the antibody. The resultant .sup.99m Tc-labeled antibody has a stable label and is useful for, inter alia, tumor imaging by gamma scintigraphy and/or tumor therapy. Rhenium-labeling can be similarly effected.
REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4421735 (1983-12-01), Haber et al.
patent: 4478815 (1984-10-01), Burchiel et al.
Steigman et al, Int. J. Appl. Rad. Isotopes, 26 (1975) 601-609.
Khaw et al, J. Nucl. Med, 23 (1982) 1011-1019.
Hnatowich et al, Int. J. Appl. Rad. Isotopes, 33 (1982) 327-332.
Hnatowich et al, J. Immunol. Meth., 65 (1983) 147-157.
Eckelman William C.
Paik Chang H.
Reba Richard C.
Nucker Christine M.
Saxe Bernard D.
LandOfFree
Method of stably radiolabeling antibodies with technetium and rh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of stably radiolabeling antibodies with technetium and rh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of stably radiolabeling antibodies with technetium and rh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1353207